Latuda (lah-TOO-dah, lurasidone) will soon compete in the crowded market of atypical antipsychotics

September 2012

Latuda (lah-TOO-dah, lurasidone) will soon compete in the crowded market of atypical antipsychotics.

It's another once-daily oral option for treating schizophrenia.

Latuda seems to work as well as other atypicals...and might be better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Cardiology when it makes sense to take MORE than 81 mg/day of aspirin to prevent cardiovascular events
Men's Health Cialis (tadalafil) promoted for benign prostatic hyperplasia (BPH)
Natural Health Products The latest supplement craze is green coffee extract
Osteoporosis more emphasis on prevention and treatment of osteoporosis in MEN
Osteoporosis how much vitamin D is needed to reduce fracture risk in adults
Psychology Latuda (lah-TOO-dah, lurasidone) will soon compete in the crowded market of atypical antipsychotics
HIV & AIDS new rapid home HIV test called OraQuick In-Home HIV Test
Psoriasis topical options for psoriasis
Transdermal Patches the right way to use patches
Herpes new debate about how to treat or prevent ACUTE shingles
Pertussis big increase in pertussis